Literature DB >> 25187910

[Risk-adapted targeted intraoperative radiotherapy versus whole breast irradiation in breast cancer patients].

Marc D Piroth.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 25187910     DOI： 10.1007/s00066-014-0700-7

Source DB:  PubMed          Journal:  Strahlenther Onkol        ISSN： 0179-7158            Impact factor:   3.621


× No keyword cloud information.
  8 in total

1.  Evaluation of dose to cardiac structures during breast irradiation.

Authors:  M C Aznar; S-S Korreman; A N Pedersen; G F Persson; M Josipovic; L Specht
Journal:  Br J Radiol       Date:  2010-12-15       Impact factor: 3.039

2.  Ischemic heart disease after breast cancer radiotherapy.

Authors:  Sarah C Darby; Marianne Ewertz; Per Hall
Journal:  N Engl J Med       Date:  2013-06-27       Impact factor: 91.245

3.  A phase III randomized study on the sequencing of radiotherapy and chemotherapy in the conservative management of early-stage breast cancer.

Authors:  Giorgio Arcangeli; Paola Pinnarò; Rita Rambone; Diana Giannarelli; Marcello Benassi
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-13       Impact factor: 7.038

4.  Cardiac dose from tangential breast cancer radiotherapy in the year 2006.

Authors:  Carolyn W Taylor; Julie M Povall; Paul McGale; Andrew Nisbet; David Dodwell; Jonathan T Smith; Sarah C Darby
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-18       Impact factor: 7.038

5.  Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial.

Authors:  Jayant S Vaidya; David J Joseph; Jeffrey S Tobias; Max Bulsara; Frederik Wenz; Christobel Saunders; Michael Alvarado; Henrik L Flyger; Samuele Massarut; Wolfgang Eiermann; Mohammed Keshtgar; John Dewar; Uta Kraus-Tiefenbacher; Marc Sütterlin; Laura Esserman; Helle M R Holtveg; Mario Roncadin; Steffi Pigorsch; Marinos Metaxas; Mary Falzon; April Matthews; Tammy Corica; Norman R Williams; Michael Baum
Journal:  Lancet       Date:  2010-07-10       Impact factor: 79.321

6.  Recurrence pattern and prognosis in low-risk breast cancer patients--data from the DBCG 89-A programme.

Authors:  Peer Christiansen; Nidal Al-Suliman; Karsten Bjerre; Susanne Møller
Journal:  Acta Oncol       Date:  2008       Impact factor: 4.089

Review 7.  Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials.

Authors:  S Darby; P McGale; C Correa; C Taylor; R Arriagada; M Clarke; D Cutter; C Davies; M Ewertz; J Godwin; R Gray; L Pierce; T Whelan; Y Wang; R Peto
Journal:  Lancet       Date:  2011-10-19       Impact factor: 79.321

8.  Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial.

Authors:  Jayant S Vaidya; Frederik Wenz; Max Bulsara; Jeffrey S Tobias; David J Joseph; Mohammed Keshtgar; Henrik L Flyger; Samuele Massarut; Michael Alvarado; Christobel Saunders; Wolfgang Eiermann; Marinos Metaxas; Elena Sperk; Marc Sütterlin; Douglas Brown; Laura Esserman; Mario Roncadin; Alastair Thompson; John A Dewar; Helle M R Holtveg; Steffi Pigorsch; Mary Falzon; Eleanor Harris; April Matthews; Chris Brew-Graves; Ingrid Potyka; Tammy Corica; Norman R Williams; Michael Baum
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321
  8 in total
  1 in total

Review 1.  Accelerated Partial Breast Irradiation in Clinical Practice.

Authors:  Frederik Wenz; Felix Sedlmayer; Carsten Herskind; Grit Welzel; Elena Sperk; Christian Neumaier; Benjamin Gauter-Fleckenstein; Jayant S Vaidya; Marc Sütterlin
Journal:  Breast Care (Basel)       Date:  2015-07-15       Impact factor: 2.860
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.